PBE vs. IHF
PBE (Invesco Dynamic Biotechnology & Genome ETF) and IHF (iShares U.S. Healthcare Providers ETF) are both Health & Biotech Equities funds - PBE tracks the Dynamic Biotech & Genome Intellidex Index (AMEX) while IHF tracks the Dow Jones U.S. Select Health Care Providers Index. Both are passively managed. Over the past 10 years, PBE returned 7.59%/yr vs 8.27%/yr for IHF. A 0.58 correlation means they provide meaningful diversification when combined. PBE charges 0.59%/yr vs 0.43%/yr for IHF.
Performance
PBE vs. IHF - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PBE achieves a 2.58% return, which is significantly lower than IHF's 7.93% return. Over the past 10 years, PBE has underperformed IHF with an annualized return of 7.59%, while IHF has yielded a comparatively higher 8.27% annualized return.
PBE
- 1D
- 1.99%
- 1M
- 4.32%
- YTD
- 2.58%
- 6M
- 3.21%
- 1Y
- 32.21%
- 3Y*
- 11.28%
- 5Y*
- 3.46%
- 10Y*
- 7.59%
IHF
- 1D
- 3.14%
- 1M
- 7.98%
- YTD
- 7.93%
- 6M
- 6.98%
- 1Y
- 10.08%
- 3Y*
- 1.25%
- 5Y*
- 0.09%
- 10Y*
- 8.27%
PBE vs. IHF - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PBE Invesco Dynamic Biotechnology & Genome ETF | 2.58% | 24.84% | 1.10% | 3.71% | -10.83% | 1.54% | 25.66% | 18.65% | -0.19% | 22.28% |
IHF iShares U.S. Healthcare Providers ETF | 7.93% | 0.92% | -7.90% | -1.11% | -7.11% | 24.46% | 17.67% | 22.34% | 9.56% | 25.45% |
Correlation
The correlation between PBE and IHF is 0.43, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.43 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.45 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.53 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.53 |
Correlation (All Time) Calculated using the full available price history since May 8, 2006 | 0.58 |
The correlation between PBE and IHF shifts across timeframes, from 0.43 (1 year) to 0.58 (all time), reflecting how their relationship changes across market environments.
PBE vs. IHF - Sectors Allocation Comparison
Sectors
PBE
IHF
Healthcare
Financial Services
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
Utilities
-
-
Healthcare
PBE
IHF
Financial Services
PBE
IHF
Basic Materials
PBE
-
IHF
-
Communication Services
PBE
-
IHF
-
Consumer Cyclical
PBE
-
IHF
-
Consumer Defensive
PBE
-
IHF
-
Energy
PBE
-
IHF
-
Industrials
PBE
-
IHF
-
Real Estate
PBE
-
IHF
-
Technology
PBE
-
IHF
Utilities
PBE
-
IHF
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PBE vs. IHF — Risk / Return Rank
PBE
IHF
PBE vs. IHF - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco Dynamic Biotechnology & Genome ETF (PBE) and iShares U.S. Healthcare Providers ETF (IHF). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PBE | IHF | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.26 | ||
| Sortino ratioReturn per unit of downside risk | +1.85 | ||
| Omega ratioGain probability vs. loss probability | 1.30 | 1.11 | +0.19 |
| Calmar ratioReturn relative to maximum drawdown | 2.76 | 0.51 | +2.25 |
| Martin ratioReturn relative to average drawdown | 7.74 | 1.19 | +6.55 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| PBE | IHF | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.72 | 0.47 | +1.26 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.15 | 0.00 | +0.15 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.31 | 0.39 | -0.09 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.33 | 0.39 | -0.06 |
Drawdowns
PBE vs. IHF - Drawdown Comparison
The maximum PBE drawdown since its inception was -45.69%, smaller than the maximum IHF drawdown of -58.42%. Use the drawdown chart below to compare losses from any high point for PBE and IHF.
Loading charts...
Drawdown Indicators
| PBE | IHF | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -45.69% | -58.42% | +12.73% |
Max Drawdown (1Y)Largest decline over 1 year | -11.73% | -19.72% | +7.99% |
Max Drawdown (3Y)Largest decline over 3 years | -22.43% | -29.85% | +7.42% |
Max Drawdown (5Y)Largest decline over 5 years | -34.71% | -29.85% | -4.86% |
Max Drawdown (10Y)Largest decline over 10 years | -37.84% | -35.23% | -2.61% |
Current DrawdownCurrent decline from peak | -1.71% | -10.44% | +8.73% |
Average DrawdownAverage peak-to-trough decline | -16.23% | -10.65% | -5.58% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.17% | 8.51% | -4.34% |
Volatility
PBE vs. IHF - Volatility Comparison
Invesco Dynamic Biotechnology & Genome ETF (PBE) and iShares U.S. Healthcare Providers ETF (IHF) have volatilities of 5.92% and 5.89%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PBE | IHF | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.92% | 5.89% | +0.03% |
Volatility (6M)Calculated over the trailing 6-month period | 13.42% | 16.11% | -2.69% |
Volatility (1Y)Calculated over the trailing 1-year period | 18.79% | 21.73% | -2.94% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.55% | 19.15% | +3.40% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.92% | 21.02% | +3.90% |
PBE vs. IHF - Expense Ratio Comparison
PBE has a 0.59% expense ratio, which is higher than IHF's 0.43% expense ratio.
Dividends
PBE vs. IHF - Dividend Comparison
PBE's dividend yield for the trailing twelve months is around 1.03%, which matches IHF's 1.03% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IHF iShares U.S. Healthcare Providers ETF | 1.03% | 1.05% | 0.86% | 0.79% | 0.74% | 0.56% | 0.53% | 0.58% | 4.01% | 0.19% | 0.25% | 0.20% |
PBE Invesco Dynamic Biotechnology & Genome ETF | 1.03% | 1.00% | 0.05% | 0.02% | 0.00% | 0.00% | 0.04% | 0.00% | 0.00% | 0.57% | 0.38% | 1.12% |
Frequently Asked Questions
PBE and IHF have a correlation of 0.43, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PBE has higher volatility (5.92%) compared to IHF (5.89%). In terms of maximum drawdown, PBE dropped -45.69% vs IHF's -58.42%.
On 10-year performance, IHF leads with 8.27% vs 7.59% for PBE. On fees, IHF is cheaper at 0.43% per year. Their volatility is very similar. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, IHF has performed better with a 8.27% return vs 7.59%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IHF is cheaper with a 0.43% expense ratio, compared with 0.59% for PBE.
PBE and IHF have nearly identical dividend yields, around 1.03%.
PBE tracks Dynamic Biotech & Genome Intellidex Index (AMEX), while IHF tracks Dow Jones U.S. Select Health Care Providers Index. They also come from different issuers: Invesco and iShares. Their fees differ too: 0.59% for PBE and 0.43% for IHF.
PBE currently has the higher Sharpe Ratio (1.72 vs 0.47), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PBE and IHF
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer